Cochlear Ltd
Cochlear Limited provides implantable hearing solutions and a range of implants and sound processor upgrades.
The business
Cochlear Limited provides implantable hearing solutions and a range of implants and sound processor upgrades. Its segments include Cochlear Implants, Services and Acoustics. The Cochlear Implants segment offers Cochlear implant systems. The Services segment offers sound processor upgrades, accessories and other. The Acoustics segment offers bone conduction systems and sound processor upgrades. Its products and services portfolio include Cochlear implant portfolio, Acoustic solutions portfolio, Recipient support tools, and Cochlear Connected Care solutions. Its Cochlear Connected Care solutions include Cochlear Nucleus SmartNav System, Cochlear Custom Sound Pro Fitting Software, Cochlear Link, Cochlear Remote Assist, and Cochlear Remote Check. Cochlear implant portfolio includes Cochlear Nucleus System. Acoustic solutions portfolio includes Cochlear Osia System, and Cochlear Baha System. Recipient support tools include Cochlear Nucleus, Baha and Osia Smart Apps and Cochlear CoPilot App.
Small Caps Research
No research on Cochlear Ltd yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise COH based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
Cochlear rejects ACCC’s concerns over Oticon Medical acquisition, Santos loses Barossa offshore drilling appeal and Beach Energy submits counterproposal
Australia’s competition watchdog, the Australian Competition and Consumer Commission (ACCC) declared it has “significant preliminary competition concerns” regarding Cochlear’s (ASX: COH) proposed $170 million acquisition of Oticon Medical. Cochlear and Oticon Medical manufacture and distribute non-surgical bone conduction devices, surgical bone anchored devices, and cochlear implant hearing devices. The ACCC released a statement fearing the […]
COVID-19 pandemic hits Cochlear and Suncorp
The COVID-19 pandemic has continued to have a big impact on Australian companies, with the latest being Cochlear (ASX: COH) and Suncorp (ASX: SUN). Cochlear chief executive officer Dig Howitt said it was still too early to predict the true impact of coronavirus on the hearing implant maker, which is in “unchartered territory” due to […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.